« Ex FDA Generic BigWig Joins Biggest Generic DrugMaker | Main | What's in Placebos: Who knows? Analysis of randomized, controlled trials »

10/19/2010

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b0133f52f8520970b

Listed below are links to weblogs that reference Pfizer Taps BioCon to Go After Biologics in Pharmerging Markets:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

bigredbruce

Following the Pfizer investment, Biocon announces a $161 M deal to add manufacturing and R&D in the Bio-Xcell biotech park in Malaysia
http://www.fiercebiotech.com/story/biocon-makes-161m-malaysian-r-d-investment/2010-10-28?utm_medium=rss&utm_source=rss

bigredbruce

Coverage of this story from the PharmaTech Talk blog detailing other Pfizer invetments in India to gain access to that emerging market
http://blog.pharmtech.com/2010/10/19/pfizer-takes-biosimilars-plunge/

bigredbruce

More on this from Fierce Biotech detailing price hit Novo Nordisk is taking today - only temporary to be sure
http://www.fiercebiotech.com/story/pfizers-new-biosimilar-insulin-pact-dents-high-flying-novo/2010-10-19?utm_medium=rss&utm_source=rss

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

April 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30      

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada